Table 2. Adjusted associations between patient characteristics and receipt of TL (vs. CTRT).
Characteristic | Adjusted Odds Ratio (95% CI) | ||||
---|---|---|---|---|---|
| |||||
Age at diagnosis | |||||
66-69 | Ref | ||||
70-74 | 0.88 (0.59 - 1.31) | ||||
75-59 | 1.09 (0.69 - 1.72) | ||||
80-84 | 1.06 (0.59 - 1.89) | ||||
85+ | 1.14 (0.5 - 2.6) | ||||
| |||||
Sex | |||||
Male | Ref | ||||
Female | 0.99 (0.66 - 1.47) | ||||
| |||||
Race | |||||
White | Ref | ||||
Black | 1.13 (0.66 - 1.94) | ||||
Other | 0.67 (0.35 - 1.31) | ||||
| |||||
Census tract median income | |||||
1st quartile | Ref | ||||
2nd quartile | 0.8 (0.5 - 1.29) | ||||
3rd quartile | 0.74 (0.45 - 1.22) | ||||
4th quartile | 0.8 (0.46 - 1.38) | ||||
| |||||
Urban-rural residence | |||||
Metro | Ref | ||||
Non-metropolitan | 1.25 (0.77 - 2.06) | ||||
| |||||
Region | |||||
Northeast | Ref | ||||
South | 1.19 (0.7 - 2.02) | ||||
Midwest | 1.31 (0.74 - 2.32) | ||||
West | 1.24 (0.8 - 1.92) | ||||
| |||||
Married | |||||
Yes | Ref | ||||
No | 1.01 (0.72 - 1.44) | ||||
Unknown | 1.48 (0.67 - 3.3) | ||||
| |||||
Site | |||||
Glottis | Ref | ||||
Supraglottis | 0.61 (0.41 - 0.91) | ||||
Other | 1.68 (1.05 - 2.7) | ||||
| |||||
Clinical T-stage | |||||
T1/T2 | Ref | ||||
T3 | 2.47 (1.42 - 4.3) | ||||
T4 | 5.62 (3.26 - 9.67) | ||||
| |||||
Lymph node involvement | |||||
Negative | Ref | ||||
Positive | 1.18 (0.81 - 1.73) | ||||
Unknown | 0.64 (0.28 - 1.46) | ||||
| |||||
Charlson comorbidity score | |||||
0 | Ref | ||||
1 | 1.04 (0.71 - 1.53) | ||||
2+ | 1.37 (0.88 - 2.13) | ||||
| |||||
Year of diagnosis | 0.81 (0.75 - 0.86) |
Abbreviations: TL, total laryngectomy; CTRT, chemoradiation; CI, confidence interval
Notes: Other site includes subglottis, overlapping tumors and cancer of the larynx not otherwise specified.